Organogenesis Holdings (ORGO) Revenue (2017 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Revenue of $37.2 million for Q1 2026, down 57.06% year-over-year from $86.7 million in Q1 2025, and down 83.5% quarter-over-quarter from $225.6 million in Q4 2025.
Organogenesis Holdings (ORGO) Revenue (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Revenue history runs 10 years deep, the most recent figure standing at $37.2 million for Q1 2026.
- In Q1 2026, Revenue fell 57.06% year-over-year to $37.2 million; the TTM figure through Mar 2026 stood at $514.7 million (up 12.19% YoY), while the FY2025 annual figure was $564.2 million, up 17.04% from the prior year.
- Revenue for Q1 2026 stood at $37.2 million, down from $225.6 million in the prior quarter.
- The five-year high for Revenue was $225.6 million in Q4 2025, with the low at $37.2 million in Q1 2026.
- The 5-year median for Revenue is $115.2 million (2024), against an average of $115.7 million.
- The sharpest annual moves came in 2025 and 2026: Revenue jumped 78.13% in 2025, then plunged 57.06% in 2026.
- Organogenesis Holdings' Revenue stood at $115.5 million in 2022, then fell by 13.73% to $99.7 million in 2023, then gained by 27.1% to $126.7 million in 2024, then soared by 78.13% to $225.6 million in 2025, then slumped by 83.5% to $37.2 million in 2026.
- Business Quant data shows ORGO's Revenue at $37.2 million in Q1 2026, $225.6 million in Q4 2025, and $150.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Organogenesis Holdings | 241.91 Mn | 195.06 Mn | 20.08 Mn | 43.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.76 Mn |
| Mar 31, 2026 | 37.23 Mn |
| Dec 31, 2025 | 225.61 Mn |
| Sep 30, 2025 | 150.86 Mn |
| Jun 30, 2025 | 101.01 Mn |
| Mar 31, 2025 | 86.69 Mn |
| Dec 31, 2024 | 126.66 Mn |
| Sep 30, 2024 | 115.18 Mn |
| Jun 30, 2024 | 130.23 Mn |
| Mar 31, 2024 | 109.98 Mn |
| Dec 31, 2023 | 99.65 Mn |
| Sep 30, 2023 | 108.53 Mn |
| Jun 30, 2023 | 117.32 Mn |
| Mar 31, 2023 | 107.64 Mn |
| Dec 31, 2022 | 115.52 Mn |
| Sep 30, 2022 | 116.86 Mn |
| Jun 30, 2022 | 121.40 Mn |
| Mar 31, 2022 | 97.12 Mn |
| Dec 31, 2021 | 127.86 Mn |
| Sep 30, 2021 | 113.75 Mn |